Holen Sie sich die Stockscreener-App
2.61
0.77%
0.02
Handel nachbörslich:
2.61
Schlusskurs vom Vortag:
$2.59
Offen:
$2.59
24-Stunden-Volumen:
537.79K
Relative Volume:
0.75
Marktkapitalisierung:
$156.29M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-40.33M
KGV:
-1.4581
EPS:
-1.79
Netto-Cashflow:
$-39.53M
1W Leistung:
+1.56%
1M Leistung:
-19.69%
6M Leistung:
-32.90%
1J Leistung:
+1.16%
1-Tages-Spanne:
$2.54
$2.625
1-Wochen-Bereich:
$2.535
$2.66
52-Wochen-Spanne:
$2.375
$5.54
Eledon Pharmaceuticals Inc Stock (ELDN) Company Profile
Firmenname
Eledon Pharmaceuticals Inc
Sektor
Branche
Telefon
949-238-8090
Adresse
19800 MACARTHUR BLVD., IRVINE
Vergleichen Sie ELDN mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ELDN
Eledon Pharmaceuticals Inc
|
2.61 | 152.70M | 0 | -40.33M | -39.53M | -1.79 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.93 | 102.81B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
453.54 | 58.59B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
567.22 | 61.25B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
733.66 | 43.23B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
318.73 | 36.53B | 3.81B | -644.79M | -669.77M | -6.24 |
Eledon Pharmaceuticals Inc Stock (ELDN) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-06-18 | Fortgesetzt | H.C. Wainwright | Buy |
| 2025-01-28 | Eingeleitet | Guggenheim | Buy |
| 2022-05-13 | Fortgesetzt | Cantor Fitzgerald | Overweight |
| 2021-03-23 | Eingeleitet | Cantor Fitzgerald | Overweight |
Eledon Pharmaceuticals Inc Aktie (ELDN) Neueste Nachrichten
Volume spikes in Eledon Pharmaceuticals Inc. stock – what they meanIPO Watch & Free Fast Entry Momentum Trade Alerts - Newser
Backtesting results for Eledon Pharmaceuticals Inc. trading strategies2025 AllTime Highs & Daily Chart Pattern Signals - Newser
Analyzing Eledon Pharmaceuticals Inc. with multi timeframe charts2025 Short Interest & Risk Adjusted Buy and Sell Alerts - Newser
Is a relief rally coming for Eledon Pharmaceuticals Inc. holders2025 Market Outlook & Low Risk Profit Maximizing Plans - Newser
Applying sector rotation models to Eledon Pharmaceuticals Inc.Market Movers & Safe Entry Trade Reports - Newser
Tools to assess Eledon Pharmaceuticals Inc.’s risk profileJuly 2025 Highlights & Technical Entry and Exit Alerts - Newser
How sentiment analysis helps forecast Eledon Pharmaceuticals Inc.Quarterly Performance Summary & Technical Entry and Exit Tips - Newser
Eledon Pharmaceuticals Inc. stock outlook for YEARQuarterly Portfolio Review & AI Driven Price Predictions - Newser
Eledon Pharmaceuticals Inc. stock trendline breakdownOptions Play & Real-Time Market Sentiment Alerts - Newser
Sector ETF performance correlation with Eledon Pharmaceuticals Inc.Weekly Gains Report & Consistent Profit Alerts - Newser
Is Eledon Pharmaceuticals Inc. forming a reversal patternJuly 2025 EndofMonth & Risk Controlled Daily Trade Plans - Newser
Is Eledon Pharmaceuticals Inc. stock bottoming outWatch List & Free Risk Controlled Daily Trade Plans - Newser
What the charts say about Eledon Pharmaceuticals Inc. todayJuly 2025 Rallies & Low Drawdown Investment Strategies - Newser
Pattern recognition hints at Eledon Pharmaceuticals Inc. upside2025 Institutional Moves & Weekly Market Pulse Updates - Newser
Will Eledon Pharmaceuticals Inc. outperform the market2025 Dividend Review & Free High Accuracy Swing Entry Alerts - Newser
Understanding Eledon Pharmaceuticals Inc.’s price movementTake Profit & Weekly Breakout Watchlists - Newser
Risk vs reward if holding onto Eledon Pharmaceuticals Inc.Weekly Trade Review & Fast Moving Stock Trade Plans - Newser
News impact scoring models applied to Eledon Pharmaceuticals Inc.Portfolio Update Summary & Stepwise Entry/Exit Trade Alerts - Newser
How to read the order book for Eledon Pharmaceuticals Inc.2025 Retail Activity & Free Accurate Trade Setup Notifications - Newser
Using fundamentals and technicals on Eledon Pharmaceuticals Inc.Trade Risk Assessment & Precise Entry and Exit Recommendations - Newser
Order flow analysis tools used on Eledon Pharmaceuticals Inc.2025 Trading Recap & Reliable Breakout Forecasts - Newser
Will Eledon Pharmaceuticals Inc. benefit from government policyQuarterly Portfolio Summary & Reliable Breakout Stock Forecasts - خودرو بانک
Can Eledon Pharmaceuticals Inc. be recession proofJuly 2025 Review & Community Trade Idea Sharing Platform - khodrobank.com
Visual analytics tools that track Eledon Pharmaceuticals Inc. performance2025 AllTime Highs & Safe Entry Point Alerts - Newser
Ranking Eledon Pharmaceuticals Inc. among high performing stocks via toolsTrade Exit Report & Growth Focused Entry Reports - Newser
How high can Eledon Pharmaceuticals Inc. stock goTrade Risk Assessment & Low Drawdown Investment Ideas - Newser
Regression analysis insights on Eledon Pharmaceuticals Inc. performanceEarnings Growth Summary & Fast Gain Stock Trading Tips - Newser
Published on: 2025-08-31 10:39:08 - Newser
How to monitor Eledon Pharmaceuticals Inc. with trend dashboardsChart Signals & Safe Entry Point Alerts - Newser
Published on: 2025-08-31 02:45:37 - Newser
Historical volatility pattern of Eledon Pharmaceuticals Inc. visualized2025 Year in Review & Daily Momentum Trading Reports - Newser
How to recover losses in Eledon Pharmaceuticals Inc. stockTrade Risk Report & Target Return Focused Stock Picks - Newser
Why Eledon Pharmaceuticals Inc. is moving todayPortfolio Return Report & Verified High Yield Trade Plans - Newser
Does Eledon Pharmaceuticals Inc. qualify in momentum factor screeningDollar Strength & AI Enhanced Trading Alerts - Newser
Exit strategy if you’re trapped in Eledon Pharmaceuticals Inc.July 2025 Opening Moves & Short-Term High Return Ideas - Newser
Will Breakout in Eledon Pharmaceuticals Inc. Sustain Through Next Week getLinesFromResByArray error: size == 0 - 더경남뉴스
Finanzdaten der Eledon Pharmaceuticals Inc-Aktie (ELDN)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.75%
1.11%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):